An unprecedented research project to discover how and why New Zealanders are using cannabis medicinally has been launched today by
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment.
Abstract The vast majority of states have enacted full or partial medical marijuana (MMJ) programs, causing the number of patients
CLEAR has formed a partnership with the research arm of GroGlo, a UK-based manufacturer of high power, LED, horticultural grow lighting. The
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease
BACKGROUND AND PURPOSE Previous findings have indicated that a cannabinoid, such as Δ9-THCV, which has antioxidant properties and the ability
Author: Mary E. Lynch Abstract Chronic pain is an escalating public health problem. Currently available treatments are inadequate to control chronic
PRNewswire: Marijuana Derivative Reduces Seizures in Children and Young Adults with Treatment-Resistant Epilepsy
NEW YORK, Dec. 23, 2015 /PRNewswire-USNewswire/ — Cannabidiol (CBD), a medical marijuana derivative, was effective in reducing seizure frequency and well-tolerated
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
Authors: Jetly R1, Heber A2, Fraser G3, Boisvert D3. Abstract OBJECTIVE: Investigate the efficacy of nabilone capsules (NAB) in reducing the
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review
Paper Authored by Kevin P. Hill, MD, MHS Full article available here and published in JAMA June 23/30, 2015, Vol 313, No. 24 Of significant